{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:43:17Z","timestamp":1769110997339,"version":"3.49.0"},"reference-count":10,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,5,27]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>A 57-year-old man presented with a progressive flaccid symmetrical motor and sensory neuropathy following a 1-week history of cough and malaise. He was diagnosed with Guillain-Barr\u00e9 syndrome secondary to COVID-19 and started on intravenous immunoglobulin. He proceeded to have worsening respiratory function and needed intubation and mechanical ventilation. This is the first reported case of this rare neurological complication of COVID-19 in the UK, but it adds to a small but growing body of international evidence to suggest a significant association between these two conditions. Increasing appreciation of this by clinicians will ensure earlier diagnosis, monitoring and treatment of patients presenting with this.<\/jats:p>","DOI":"10.1136\/bcr-2020-236182","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T06:15:33Z","timestamp":1592201733000},"page":"e236182","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":72,"title":["Guillain-Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication"],"prefix":"10.1136","volume":"13","author":[{"given":"Silas","family":"Webb","sequence":"first","affiliation":[{"name":"Department of Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria CJ","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Martin-Lopez","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology, St George's University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahinda","family":"Yogarajah","sequence":"additional","affiliation":[{"name":"Department of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,6,14]]},"reference":[{"key":"2025082804083299000_13.6.e236182.1","unstructured":"Mao L , Wang M , Chen S , et al . Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China. JAMA Neurol."},{"key":"2025082804083299000_13.6.e236182.2","doi-asserted-by":"crossref","unstructured":"Zhao H , Shen D , Zhou H , et al . Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;4.","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2025082804083299000_13.6.e236182.3","doi-asserted-by":"crossref","unstructured":"Sedaghat Z , Karimi N . Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 2020;4.doi:10.1016\/j.jocn.2020.04.062","DOI":"10.1016\/j.jocn.2020.04.062"},{"key":"2025082804083299000_13.6.e236182.4","doi-asserted-by":"crossref","unstructured":"Virani A , Rabold E , Hanson T , et al . Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. IDCases 2020;4.","DOI":"10.1016\/j.idcr.2020.e00771"},{"key":"2025082804083299000_13.6.e236182.5","doi-asserted-by":"crossref","unstructured":"Toscano G , Palmerini F , Dm RS , et al . Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med 2020;4.","DOI":"10.1056\/NEJMc2009191"},{"key":"2025082804083299000_13.6.e236182.6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"2025082804083299000_13.6.e236182.7","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"key":"2025082804083299000_13.6.e236182.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30058-7"},{"key":"2025082804083299000_13.6.e236182.9","doi-asserted-by":"publisher","DOI":"10.1159\/000324710"},{"key":"2025082804083299000_13.6.e236182.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-236182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:08:43Z","timestamp":1756379323000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-236182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,14]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bcr-2020-236182"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-236182","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}